Clinical Study of Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History Caused by Abnormal Uterine Natural Killer Cells

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

The aim of this study is preliminary exploration of the effectiveness and duration of autologous decidual-like NK cells therapy in improving uterine NK cells dysfunction.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 22
Maximum Age: 40
Healthy Volunteers: f
View:

• abnormal uterine NK cell function;

• have one of the following medical history: unexplained recurrent spontaneous abortions (≥2 spontaneous abortions, including biochemical pregnancy), repeated implantation failure (failure of implantation of good-quality embryos in at least two IVF cycles), unexplained infertility, early-onset severe gestational hypertension or early-onset fetal growth restriction;

• have clear fertility desires;

• normal ovarian function or with frozen embryos;

• edometrium thickness measured by vaginal ultrasound before ovulation or at mid-luteal phase \>= 7mm;

• 18kg/m\^2 \< Body mass index \< 30kg/m\^2;

Locations
Other Locations
China
The Affiliated Drum Tower Hospital of Nanjing University
RECRUITING
Nanjing
Contact Information
Primary
Yali Hu
glyyhuyali@163.com
86-025-83106666
Backup
Hui Zhu
zhuhui1231@126.com
86-025-83106666
Time Frame
Start Date: 2025-02
Estimated Completion Date: 2027-12
Participants
Target number of participants: 14
Treatments
Experimental: autologous decidual-like NK cells
Autologous decidual like NK cells will be isolated and induced in vitro culture from the patients' peripheral blood and perfused into their uterine.
Related Therapeutic Areas
Sponsors
Collaborators: The University of Science and Technology of China
Leads: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

This content was sourced from clinicaltrials.gov